XML 24 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Operating activities:      
Net (loss) income $ (9,229) $ 9,432 $ 9,328
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Amortization of acquisition-related intangible assets 20,370 21,336 22,076
Stock-based compensation plan expense 42,044 41,695 34,200
Depreciation and other amortization 27,232 22,911 19,994
Gain on sale of investments 0 (7,599) (2,419)
Deferred income tax benefit (829) (5,147) (9,465)
Provision for allowances on accounts receivable 749 220 238
Amortization of debt issuance costs 414 414 928
Amortization of debt discount 0 0 5,574
Amortization of discount on investments (56) (137) (62)
Fair value adjustment on other investments (49) 0 0
(Gain) loss on sale of property and equipment (427) 623 65
Loss (gain) on foreign exchange 603 497 (106)
Changes in operating assets and liabilities:      
Accounts receivable 5,763 (4,303) (9,675)
Prepaid expenses and other current assets 1,548 (3,760) (1,023)
Operating lease right-of-use asset, net 1,575    
Other assets (3,890) (3,120) (222)
Customer account liabilities 811 3,023 (5,278)
Accounts payable 2,007 580 157
Accrued expenses 4,025 279 4,056
Operating lease liabilities (1,475)    
Deferred revenue 4,540 1,689 2,852
Other liabilities 1,445 (356) (468)
Net cash provided by operating activities 97,171 78,277 70,750
Investing activities:      
Acquisition of businesses and assets, net of cash acquired 0 (24,036) (5,741)
Acquisition of building 0 (20,700) 0
Purchases of investments (238) (230) 0
Proceeds from sale of investments 38 9,011 4,415
Issuance of note receivable (1,000) 0 0
Purchases of available-for-sale securities (13,485) (8,381) (14,188)
Proceeds from sales of available-for-sale securities 10,900 11,000 6,203
Capital expenditures, including capitalization of software costs (46,650) (33,083) (21,376)
Proceeds from disposal of property and equipment 2,905 0 10
Insurance proceeds received for damage to equipment 0 201 0
Net cash used in investing activities (47,530) (66,218) (30,677)
Financing activities:      
Repurchase of common stock (19,145) 0 0
Repayment of amounts borrowed under revolving credit facility (10,000) (40,000) (189,750)
Amounts borrowed under revolving credit facility 80,000 0 150,000
Repayment of notes payable (365) (736) (2,581)
Settlement of warrants 0 (4) (2)
Debt issuance costs related to credit facility 0 (597) 0
Proceeds from exercise of stock options and employee stock purchase plan 4,134 3,924 3,509
Net cash provided by (used in) financing activities 54,624 (37,413) (38,824)
Effect of exchange rate changes on cash (930) (1,458) (1,205)
Increase (decrease) in cash and cash equivalents 103,335 (26,812) 44
Cash, cash equivalents and restricted cash at beginning of period 97,801 124,613 124,569
Cash, cash equivalents and restricted cash at end of period 201,136 97,801 124,613
Cash and cash equivalents at end of period 194,832 92,164 121,860
Cash held for customers at end of period 6,304 5,637 2,753
Cash, cash equivalents and restricted cash at end of period 97,801 124,613 124,613
Supplemental disclosure of cash flow information:      
Interest, net of amounts capitalized 3,105 3,936 4,873
Income taxes 3,100 2,040 3,109
Non-cash financing activities:      
Issuance of common stock upon settlement of the warrants 0 58,451 12,739
Issuance of note payable to seller in connection with acquisition 0 0 1,836
Issuance of common stock upon conversion of convertible senior notes 0 0 19,736
Receipt of common stock upon settlement of Note Hedges $ 0 $ 0 $ 19,964